Skip to main content

Articles

Page 9 of 59

  1. The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10–12, 2022. Following the tradition of previous summits, this reference congr...

    Authors: Oliver Schnell, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, Steve Edelman, Thomas Forst, Francesco Giorgino, Jennifer Green, Per-Henrik Groop, Samy Hadjadj, Hiddo J.L.Heerspink, Marcus Hompesch, Baruch Izthak…
    Citation: Cardiovascular Diabetology 2023 22:59
  2. Previous studies showed that the triglyceride-glucose (TyG) index was a better predictor of adverse cardiovascular events than triglycerides or fasting blood glucose alone. However, few studies have focused on...

    Authors: Qi Gao, Yuxin Lin, Ruqi Xu, Fan Luo, Ruixuan Chen, Pingping Li, Yuping Zhang, Jiao Liu, Zhenan Deng, Yanqin Li, Licong Su and Sheng Nie
    Citation: Cardiovascular Diabetology 2023 22:58
  3. Patients with type 2 diabetes are at increased risk for cardiovascular diseases. Sodium-glucose transport 2 inhibitors (SGLT2i) have been shown to enhance cardiovascular health since their debut as a second-li...

    Authors: Pei-Chien Tsai, Wei-Jung Chuang, Albert Min-Shan Ko, Jui-Shuan Chen, Cheng-Hsun Chiu, Chun-Han Chen and Yung-Hsin Yeh
    Citation: Cardiovascular Diabetology 2023 22:57
  4. The triglyceride–glucose (TyG) index has been shown to be an independent predictor for the progression and prognosis of coronary artery disease (CAD). Whether the TyG index predicts the severity of CAD in pati...

    Authors: Shiqiang Xiong, Qiang Chen, Yu Long, Hong Su, Yan Luo, Hanxiong Liu, Yingzhong Chen, Qiao Feng, Xiufen Peng, Maoling Jiang, Xiuqiong Yu, Zhen Zhang and Lin Cai
    Citation: Cardiovascular Diabetology 2023 22:56
  5. Diabetes mellitus (DM) is considered a major risk factor for myocardial infarction (MI), and MI patients with DM have a poor prognosis. Accordingly, we aimed to investigate the additive effects of DM on LV def...

    Authors: Yue Gao, Rui Shi, Yuan Li, Ying-kun Guo, Hua-Yan Xu, Ke Shi and Zhi-gang Yang
    Citation: Cardiovascular Diabetology 2023 22:55
  6. No study has compared the cardiovascular outcomes for sodium–glucose cotransporter-2 inhibitors (SGLT2i) head-to-head against other glucose-lowering therapies, including dipeptidyl peptidase 4 inhibitor (DDP4i...

    Authors: Jimmy Gonzalez, Benjamin A. Bates, Soko Setoguchi, Tobias Gerhard and Chintan V. Dave
    Citation: Cardiovascular Diabetology 2023 22:54
  7. To evaluate the protective effect of oral antidiabetic drugs in a large cohort of elderly patients with type 2 diabetes differing for age, clinical status, and life expectancy, including patients with multiple...

    Authors: Federico Rea, Laura Savaré, Valeria Valsassina, Stefano Ciardullo, Gianluca Perseghin, Giovanni Corrao and Giuseppe Mancia
    Citation: Cardiovascular Diabetology 2023 22:53
  8. In clinical practice, anthropometric measures other than BMI are rarely assessed yet may be more predictive of cardiovascular (CV) risk. We analyzed the placebo group of the REWIND CV Outcomes Trial to compare...

    Authors: Edward Franek, Prem Pais, Jan Basile, Claudia Nicolay, Sohini Raha, Ana Hickey, Nadia N. Ahmad, Manige Konig, Hong Kan and Hertzel C. Gerstein
    Citation: Cardiovascular Diabetology 2023 22:52
  9. Diabetes mellitus (DM) is a well-established determinant of atherosclerosis and cardiovascular diseases (CVD). Recently, genome-wide association studies (GWAS) identified several single nucleotide polymorphism...

    Authors: Tzu-Wei Wu, Chao-Liang Chou, Chun-Fang Cheng, Shu-Xin Lu, Yih-Jer Wu and Li-Yu Wang
    Citation: Cardiovascular Diabetology 2023 22:51
  10. Basal insulin glargine has a neutral effect on cardiovascular risk in type 2 diabetes (T2DM). In practice, basal insulin is often paired with a glucagon-like peptide-1 receptor agonist (GLP1-RA) or meal insuli...

    Authors: Ravi Retnakaran, Jiajie Pu, Chang Ye, Alexandra Emery, Caroline K. Kramer and Bernard Zinman
    Citation: Cardiovascular Diabetology 2023 22:50
  11. Patients with type 2 diabetes (T2D) treated with glucagon-like peptide-1 receptor agonists may experience reductions in weight and blood pressure. The primary objective of the current study was to determine th...

    Authors: Keith C. Ferdinand, Julia Dunn, Claudia Nicolay, Flora Sam, Emily K. Blue and Hui Wang
    Citation: Cardiovascular Diabetology 2023 22:49
  12. Ectopic fat is fat that accumulates in or around specific organs or compartments of the body including myocardium. The clinical features of type 2 diabetes patients with high fat accumulation in the myocardium...

    Authors: Risa Kashiwagi-Takayama, Junji Kozawa, Yoshiya Hosokawa, Sarasa Kato, Satoshi Kawata, Harutoshi Ozawa, Ryohei Mineo, Chisaki Ishibashi, Megu Y. Baden, Ryuya Iwamoto, Kenji Saisho, Yukari Fujita, Sachiko Tamba, Takuya Sugiyama, Hitoshi Nishizawa, Norikazu Maeda…
    Citation: Cardiovascular Diabetology 2023 22:48
  13. Both long-term glycaemic variability and arterial stiffness have been recognized as cardiovascular risk factors. This study aims to investigate whether an association between these phenomena exists in individu...

    Authors: Anniina Tynjälä, Valma Harjutsalo, Fanny Jansson Sigfrids, Per-Henrik Groop and Daniel Gordin
    Citation: Cardiovascular Diabetology 2023 22:47

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:83

  14. To examine the joint association of diabetes status and N-terminal pro-B-type natriuretic peptide (NT-proBNP) with subsequent risk of major adverse cardio-cerebral events (MACCEs) and all-cause mortality in pa...

    Authors: Man Wang, Wen Su, Hui Chen and Hongwei Li
    Citation: Cardiovascular Diabetology 2023 22:46
  15. Epicardial adipose tissue (EAT) accumulation is associated with multiple cardiometabolic risk factors and prognosis of heart failure with preserved ejection fraction (HFpEF). The correlation between EAT densit...

    Authors: Jie Liu, Qi Yu, Ziyang Li, Yujiao Zhou, Zhiqiang Liu, Linna You, Li Tao, Qian Dong, Ziyu Zuo, Lei Gao and Dongying Zhang
    Citation: Cardiovascular Diabetology 2023 22:45
  16. Obesity is a negative chronic metabolic health condition that represents an additional risk for the development of multiple pathologies. Epidemiological studies have shown how maternal obesity or gestational d...

    Authors: Juan José Alba-Linares, Raúl F. Pérez, Juan Ramón Tejedor, David Bastante-Rodríguez, Francisco Ponce, Nuria García Carbonell, Rafael Gómez Zafra, Agustín F. Fernández, Mario F. Fraga and Empar Lurbe
    Citation: Cardiovascular Diabetology 2023 22:44
  17. The triglyceride-glucose (TyG) index, a reliable surrogate indicator of insulin resistance, is independently associated with coronary artery disease of various clinical manifestations. This study aimed to inve...

    Authors: Xuantong Guo, Ruihuan Shen, Siyu Yan, Yanni Su and Lihong Ma
    Citation: Cardiovascular Diabetology 2023 22:43
  18. The prevalence of prediabetes is increasing in young adults and patients undergoing coronary angiography. However, whether prediabetes is a considerable risk factor for all-cause mortality remains undetermined...

    Authors: Yibo He, Hongyu Lu, Yihang Ling, Jin Liu, Sijia Yu, Ziyou Zhou, Tian Chang, Yong Liu, Shiqun Chen and Jiyan Chen
    Citation: Cardiovascular Diabetology 2023 22:42

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:155

  19. Identifying and reducing cardiometabolic risks driven by obesity remains a healthcare challenge. The metabolic syndrome is associated with abdominal obesity and inflammation and is predictive of long-term risk...

    Authors: Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad and Signe S. Torekov
    Citation: Cardiovascular Diabetology 2023 22:41
  20. There are limited data on head-to-head comparative risk of stroke between sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). We compared risk of stroke ...

    Authors: David Tak Wai Lui, Eric Ho Man Tang, Tingting Wu, Ivan Chi Ho Au, Chi Ho Lee, Yu Cho Woo, Kathryn Choon Beng Tan and Carlos King Ho Wong
    Citation: Cardiovascular Diabetology 2023 22:40
  21. Red cell distribution width/albumin ratio (RAR) is thought to be associated with the prognosis of a variety of diseases, including diabetes and heart failure. To date, no studies have focused on the relationsh...

    Authors: Mengnan Huang, Fanfan Liu, Zhu Li, Yijia Liu, Jinyu Su, Mei Ma, Yuanyuan He, Huaien Bu, Shan Gao, Hongwu Wang and Chunquan Yu
    Citation: Cardiovascular Diabetology 2023 22:39
  22. Diabetes mellitus (DM) is associated with various cardiovascular complications, including sudden cardiac arrest (SCA). Furthermore, the severity of DM, as assessed by fasting blood glucose (FBG), is associated...

    Authors: Yun Gi Kim, Seung-Young Roh, Joo Hee Jeong, Hyoung Seok Lee, Kyongjin Min, Yun Young Choi, Kyung-Do Han, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2023 22:38
  23. Diabetes mellitus is one of the prime risk factors for cardiovascular complications and is linked with high morbidity and mortality. Diabetic cardiomyopathy (DCM) often manifests as reduced cardiac contractili...

    Authors: Santosh K Sanganalmath, Shubham Dubey, Sudhakar Veeranki, Keerthy Narisetty and Prasanna Krishnamurthy
    Citation: Cardiovascular Diabetology 2023 22:37
  24. Dyslipidemia measured as low-density lipoprotein (LDL)-cholesterol is an established risk factor of cardiovascular disease, which is more pronounced in diabetes population. Less is known about the association ...

    Authors: Yun Gi Kim, Joo Hee Jeong, Kyung-Do Han, Seung-Young Roh, Kyongjin Min, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2023 22:36
  25. The glycemic continuum often indicates a gradual decline in insulin sensitivity leading to an increase in glucose levels. Although prediabetes is an established risk factor for both macrovascular and microvasc...

    Authors: Jung-Chi Hsu, Yen-Yun Yang, Shu-Lin Chuang, Lian-Yu Lin and Tony Hsiu-Hsi Chen
    Citation: Cardiovascular Diabetology 2023 22:35
  26. The triglyceride-glucose (TyG) index and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, two simple surrogate indicators of insulin resistance, have been demonstrated to predict cardiova...

    Authors: Bizhong Che, Chongke Zhong, Ruijie Zhang, Liyuan Pu, Tian Zhao, Yonghong Zhang and Liyuan Han
    Citation: Cardiovascular Diabetology 2023 22:34
  27. The 2019 guidelines for cardiovascular risk stratification by the European Society of Cardiology and European Association for the Study of Diabetes (ESC-EASD) suggested screening for silent coronary disease in...

    Authors: Paul Valensi, Narimane Berkane, Sara Pinto, Nicolas Sellier, Michael Soussan, Minh Tuan Nguyen and Emmanuel Cosson
    Citation: Cardiovascular Diabetology 2023 22:33
  28. Sex differences characterize cardiovascular outcomes in patients with type 1 diabetes. Cardioautonomic neuropathy is a common complication of type 1 diabetes that associates increased morbi-mortality. Data reg...

    Authors: Lía Nattero-Chávez, María Insenser, Alejandra Quintero Tobar, Elena Fernández-Durán, Beatriz Dorado Avendaño, Tom Fiers, Jean-Marc Kaufman, Manuel Luque-Ramírez and Héctor F. Escobar-Morreale
    Citation: Cardiovascular Diabetology 2023 22:32
  29. The aim of this study was to assess the prevalence of prediabetes and unknown diabetes and its long-term change in a large middle-aged urban population.

    Authors: Marie Hauguel-Moreau, Hélène Hergault, Laure Cazabat, Marion Pépin, Alain Beauchet, Vincent Aïdan, Mounir Ouadahi, Loïc Josseran, Mirella Hage, Christophe Rodon, Olivier Dubourg, Ziad Massy and Nicolas Mansencal
    Citation: Cardiovascular Diabetology 2023 22:31
  30. Previous studies have mainly focused more on how diabetes affects the valve than the myocardium in aortic stenosis (AS). In the pressure-overloaded heart, myocardial fibrosis is an important driver of the prog...

    Authors: Hyun-Jung Lee, Chan Soon Park, Sahmin Lee, Jun-Bean Park, Hyung-Kwan Kim, Sung-Ji Park, Yong-Jin Kim and Seung-Pyo Lee
    Citation: Cardiovascular Diabetology 2023 22:30
  31. Stress hyperglycemia ratio (SHR) is significantly related to adverse cardiovascular clinical outcomes and increased in-hospital mortality. However, the relationship between SHR and coronary artery disease (CAD...

    Authors: Yu Zhang, Haiyan Song, Jing Bai, Jiahui Xiu, Ganggang Wu, Liao Zhang, Yunhe Wu and Ying Qu
    Citation: Cardiovascular Diabetology 2023 22:29
  32. Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the sa...

    Authors: Mauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, Francesco Condello, Gaetano Liccardo, Matteo Maurina, Marisa Avvedimento, Damiano Regazzoli, Paolo Pagnotta, Hector M. Garcia-Garcia, Roxana Mehran, Massimo Federici, Gianluigi Condorelli, Jose Luis Diez Gil, Bernhard Reimers, Giuseppe Ferrante…
    Citation: Cardiovascular Diabetology 2023 22:28
  33. The novel sodium-glucose co-transporter 2 inhibitor (SGLT2i) potentially ameliorates heart failure and reduces cardiac arrhythmia. Cardiac fibrosis plays a pivotal role in the pathophysiology of HF and atrial ...

    Authors: Cheng-Chih Chung, Yung-Kuo Lin, Yao-Chang Chen, Yu-Hsun Kao, Yung-Hsin Yeh, Nguyen Ngoc Trang and Yi-Jen Chen
    Citation: Cardiovascular Diabetology 2023 22:27
  34. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their benefits occur also during hospitali...

    Authors: Filippo Trombara, Nicola Cosentino, Alice Bonomi, Monica Ludergnani, Paolo Poggio, Luigia Gionti, Marta Baviera, Pierluca Colacioppo, Maria Carla Roncaglioni, Olivia Leoni, Francesco Bortolan, Piergiuseppe Agostoni, Stefano Genovese and Giancarlo Marenzi
    Citation: Cardiovascular Diabetology 2023 22:26
  35. Increased acid sphingomyelinase (ASMase) activity is associated with insulin resistance and cardiac dysfunction. However, the effects of ASMase on diabetic cardiomyopathy (DCM) and the molecular mechanism(s) u...

    Authors: Ruijiao Liu, Tengfei Duan, Li Yu, Yongzhong Tang, Shikun Liu, Chunjiang Wang and Wei-Jin Fang
    Citation: Cardiovascular Diabetology 2023 22:25
  36. Sodium-glucose co-transporters (SGLT) inhibitors (SGLT2i) showed many beneficial effects at the cardiovascular level. Several mechanisms of action have been identified. However, no data on their capability to ...

    Authors: Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Surina, Vittoria Cataldo, Puja Ghosh, Martina Franzese, Armando Puocci, Pasquale Paolisso, Concetta Rafaniello, Raffaele Marfella, Maria Rosaria Rizzo, Emanuele Barbato, Marc Vanderheyden and Michelangela Barbieri
    Citation: Cardiovascular Diabetology 2023 22:24
  37. Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and could be a potential therapeutic target for drugs that already show cardiovascular benefits. Th...

    Authors: Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, Vincenza Valerio, Maddalena Conte, Ilaria Massaiu, Michele Bozzi, Fabrizio Celeste, Dario Leosco, Guido Iaccarino, Stefano Genovese and Paolo Poggio
    Citation: Cardiovascular Diabetology 2023 22:23
  38. Fractional Flow Reserve (FFR) is a widely applied invasive physiological assessment, endorsed by major guidelines to aid in the decision to perform or defer revascularisation. While a threshold of  > 0.8 has b...

    Authors: Avedis Ekmejian, Hari Sritharan, Dinesh Selvakumar, Venkateshka Venkateshka, Usaid Allahwala, Michael Ward and Ravinay Bhindi
    Citation: Cardiovascular Diabetology 2023 22:22
  39. Although a great deal of scientific evidence on the epidemiological risk factors for diabetes and prediabetes has been accumulated, there is still insufficient evidence to explore sex-related differences. The ...

    Authors: Yumeng Shi and Minghua Wen
    Citation: Cardiovascular Diabetology 2023 22:19
  40. Patients with concurrent atrial fibrillation (AF) and diabetes mellitus (DM) [AF-DM] have a high risk of cardiovascular and diabetes-related complications, but are less engaged in a comprehensive treatment app...

    Authors: So-Ryoung Lee, Hyo-Jeong Ahn, Eue-Keun Choi, Seung-Woo Lee, Kyung-Do Han, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:18
  41. Type 2 Diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease and associated with poor outcome after myocardial infarction (MI). In T2DM, cardiac metabolic flexibility, i.e. the switch betw...

    Authors: C. Binsch, D. M. Barbosa, G. Hansen-Dille, M. Hubert, S. M. Hodge, M. Kolasa, K. Jeruschke, J. Weiß, C. Springer, S. Gorressen, J. W. Fischer, M. Lienhard, R. Herwig, S. Börno, B. Timmermann, A. L. Cremer…
    Citation: Cardiovascular Diabetology 2023 22:17
  42. As indications for sodium-glucose co-transporter-2 inhibitors (SGLT2i) are expanding, a growing number of older adults have become candidates for treatment. We studied the safety profile of SGLT2i among older ...

    Authors: Adam Goldman, Boris Fishman, Gilad Twig, Emanuel Raschi, Tali Cukierman-Yaffe, Yonatan moshkovits, Alon Pomerantz, Ilan Ben-Zvi, Rachel Dankner and Elad Maor
    Citation: Cardiovascular Diabetology 2023 22:16
  43. To explore the additive effects of anemia on left ventricular (LV) global strains in patients with type 2 diabetes mellitus (T2DM) with or without anemia via cardiac magnetic resonance (CMR) feature tracking t...

    Authors: Wen-Lei Qian, Rong Xu, Rui Shi, Yuan Li, Ying-Kun Guo, Han Fang, Li jiang and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:15
  44. Patients with type 2 diabetes mellitus (T2DM) are highly susceptible to cardiovascular disease, and coronary artery disease (CAD) is their leading cause of death. We aimed to assess whether computed tomography...

    Authors: Xiaolin Dong, Na Li, Chentao Zhu, Yujia Wang, Ke Shi, Hong Pan, Shuting Wang, Zhenzhou Shi, Yayuan Geng, Wei Wang and Tong Zhang
    Citation: Cardiovascular Diabetology 2023 22:14
  45. Prediction model has been the focus of studies since the last century in the diagnosis and prognosis of various diseases. With the advancement in computational technology, machine learning (ML) has become the ...

    Authors: Ooi Ting Kee, Harmiza Harun, Norlaila Mustafa, Nor Azian Abdul Murad, Siok Fong Chin, Rosmina Jaafar and Noraidatulakma Abdullah
    Citation: Cardiovascular Diabetology 2023 22:13
  46. Patients with diabetes mellitus have an increased risk of incident atrial fibrillation (AF). The effect of accumulated hypertension burden is a less well-known modifiable risk factor. We explored the relations...

    Authors: JungMin Choi, So‑Ryoung Lee, Eue‑Keun Choi, HuiJin Lee, MinJu Han, Hyo-Jeong Ahn, Soonil Kwon, Seung-Woo Lee, Kyung‑Do Han, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:12
  47. Stress hyperglycemia ratio (SHR) is a novel biomarker of true acute hyperglycemia condition and is associated with a worse prognosis in patients with myocardial infarction (MI). However, the effects of SHR in ...

    Authors: Fuad A. Abdu, Jassur Galip, Penglong Qi, Wen Zhang, Abdul-Quddus Mohammed, Lu Liu, Guoqing Yin, Ayman A. Mohammed, Redhwan M. Mareai, Rong Jiang, Yawei Xu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:11
  48. The triglyceride-glucose (TyG) index is a reliable alternative biomarker of insulin resistance (IR). However, whether the TyG index has prognostic value in critically ill patients with coronary heart disease (...

    Authors: Rongting Zhang, Shanshan Shi, Weihua Chen, Yani Wang, Xueqin Lin, Yukun Zhao, Lihua Liao, Qian Guo, Xiaoying Zhang, Weiguo Li, Kaijun Zhang, Ying Liao and Yong Fang
    Citation: Cardiovascular Diabetology 2023 22:10

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions